Fresenius Medical Care AG
FMS23.060USD
+0.315+1.38%
收盘 01/09, 16:00（美东）报价延迟15分钟
6.68B总市值
16.96市盈率 TTM
关于 Fresenius Medical Care AG 公司
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. It has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. It develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. It owns, operates, or manages dialysis clinics sells products to other dialysis providers.
Fresenius Medical Care AG简介
公司代码FMS
公司名称Fresenius Medical Care AG
上市日期Oct 02, 1996
CEOCordola (Craig)
员工数量111513
证券类型Depository Receipt
年结日Oct 02
公司地址Else-Kroener-Strasse 1
城市BAD HOMBURG VOR DER HOHE
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家Germany
邮编61352
电话4961726090
网址https://www.freseniusmedicalcare.com/
公司代码FMS
上市日期Oct 02, 1996
CEOCordola (Craig)
Fresenius Medical Care AG公司高管
名称
名称/职务
职务
持股
持股变动
Ms. Pascale Witz
Ms. Pascale Witz
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Dominik Heger
Dr. Dominik Heger
Head of Investor Relations, Strategic Development and Communications, EVP
Head of Investor Relations, Strategic Development and Communications, EVP
--
--
Dr. Katarzyna Mazur-Hofsaess
Dr. Katarzyna Mazur-Hofsaess
Member of the Management Board, Chief Executive Officer - Care Enablement
Member of the Management Board, Chief Executive Officer - Care Enablement
--
--
Dr. Frank W. Maddux, M.D.
Dr. Frank W. Maddux, M.D.
Member of the Management Board, Global Chief Medical Officer
Member of the Management Board, Global Chief Medical Officer
--
--
Ms. Helen Giza
Ms. Helen Giza
Chairman of the Management Board, Chief Executive Officer
Chairman of the Management Board, Chief Executive Officer
--
--
Mr. A. Gregory Sorensen, M.D.
Mr. A. Gregory Sorensen, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Martin Fischer
Mr. Martin Fischer
Chief Financial Officer, Member of the Management Board
Chief Financial Officer, Member of the Management Board
--
--
Mr. Craig Cordola, Ed.D.
Mr. Craig Cordola, Ed.D.
Member of the Management Board, Chief Executive Officer - Care Delivery
Member of the Management Board, Chief Executive Officer - Care Delivery
--
--
Mr. Michael Sen
Mr. Michael Sen
Chairman of the Supervisory Board
Chairman of the Supervisory Board
--
--
Mr. Shervin J. Korangy
Mr. Shervin J. Korangy
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Ms. Pascale Witz
Ms. Pascale Witz
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Dominik Heger
Dr. Dominik Heger
Head of Investor Relations, Strategic Development and Communications, EVP
Head of Investor Relations, Strategic Development and Communications, EVP
--
--
Dr. Katarzyna Mazur-Hofsaess
Dr. Katarzyna Mazur-Hofsaess
Member of the Management Board, Chief Executive Officer - Care Enablement
Member of the Management Board, Chief Executive Officer - Care Enablement
--
--
Dr. Frank W. Maddux, M.D.
Dr. Frank W. Maddux, M.D.
Member of the Management Board, Global Chief Medical Officer
Member of the Management Board, Global Chief Medical Officer
--
--
Ms. Helen Giza
Ms. Helen Giza
Chairman of the Management Board, Chief Executive Officer
Chairman of the Management Board, Chief Executive Officer
--
--
Mr. A. Gregory Sorensen, M.D.
Mr. A. Gregory Sorensen, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
收入明细
单位: USD更新时间: 1月6日 周二
单位: USD更新时间: 1月6日 周二
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
由于公司未披露，未能获取相关数据
地区USD
名称
营收
占比
North America
14.78B
70.68%
Rest of the world
5.61B
26.84%
Germany
518.03M
2.48%
业务
地区
由于公司未披露，未能获取相关数据
股东统计
更新时间: 11月16日 周日
更新时间: 11月16日 周日
持股股东
股东类型
持股股东
持股股东
占比
Pzena Investment Management, LLC
2.56%
Wellington Management Company, LLP
1.42%
Fiduciary Management, Inc.
0.94%
Dodge & Cox
0.66%
Todd Asset Management LLC
0.22%
其他
94.20%
持股股东
持股股东
占比
Pzena Investment Management, LLC
2.56%
Wellington Management Company, LLP
1.42%
Fiduciary Management, Inc.
0.94%
Dodge & Cox
0.66%
Todd Asset Management LLC
0.22%
其他
94.20%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
5.15%
Investment Advisor
2.13%
Hedge Fund
0.35%
Research Firm
0.25%
Pension Fund
0.14%
Family Office
0.02%
Bank and Trust
0.01%
其他
91.95%
机构持股
更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
346
46.58M
8.04%
-2.99M
2025Q3
337
47.00M
8.12%
-7.47K
2025Q2
350
47.02M
8.22%
+2.00M
2025Q1
348
45.04M
8.08%
-2.40M
2024Q4
337
43.94M
8.01%
+456.34K
2024Q3
325
43.49M
7.70%
+2.26M
2024Q2
343
41.23M
8.48%
-1.66M
2024Q1
362
42.90M
8.31%
-5.86M
2023Q4
362
42.80M
8.39%
+76.36K
2023Q3
367
42.72M
8.58%
-1.02M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Pzena Investment Management, LLC
14.82M
2.56%
+153.87K
+1.05%
Sep 30, 2025
Wellington Management Company, LLP
8.20M
1.42%
--
--
Sep 30, 2025
Fiduciary Management, Inc.
5.46M
0.94%
-198.98K
-3.52%
Sep 30, 2025
Dodge & Cox
3.83M
0.66%
--
--
Sep 30, 2025
Todd Asset Management LLC
1.30M
0.22%
+64.31K
+5.19%
Sep 30, 2025
Aristotle Capital Management, LLC
1.13M
0.2%
-7.00K
-0.61%
Sep 30, 2025
Parametric Portfolio Associates LLC
985.01K
0.17%
+12.65K
+1.30%
Sep 30, 2025
Morgan Stanley & Co. International Plc
908.00K
0.16%
-350.00K
-27.82%
Sep 30, 2025
Janus Henderson Investors
829.14K
0.14%
+300.92K
+56.97%
Jun 30, 2025
Kentucky Teachers' Retirement System
816.20K
0.14%
+62.70K
+8.32%
Sep 30, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Cultivar ETF
1.01%
ActivePassive International Equity ETF
0.08%
Avantis Responsible International Equity ETF
0.06%
Avantis International Equity ETF
0.01%
Pacer Developed Markets International Cash Cws 100
0%
Unusual Whales Subversive Democratic Trading ETF
0%
DFA Dimensional International Core Equity 2 ETF
0%
SGI Enhanced Global Income ETF
0%
Unusual Whales Subversive Republican Trading ETF
0%
The Opal International Dividend Income ETF
0%
查看更多
Cultivar ETF
占比1.01%
ActivePassive International Equity ETF
占比0.08%
Avantis Responsible International Equity ETF
占比0.06%
Avantis International Equity ETF
占比0.01%
Pacer Developed Markets International Cash Cws 100
占比0%
Unusual Whales Subversive Democratic Trading ETF
占比0%
DFA Dimensional International Core Equity 2 ETF
占比0%
SGI Enhanced Global Income ETF
占比0%
Unusual Whales Subversive Republican Trading ETF
占比0%
The Opal International Dividend Income ETF
占比0%
分红派息
近5年累计派现
1.59B
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
May 07, 2025
FMS.NB Final Cash Dividend of gross USD 0.814968 paid on Jun 06, 2025 going ex on May 23, 2025
May 23, 2025
Jun 06, 2025
May 23, 2025
Apr 15, 2024
FMS.NB Final Cash Dividend of gross USD 0.642838 paid on Jun 03, 2024 going ex on May 17, 2024
May 20, 2024
Jun 03, 2024
May 17, 2024
May 03, 2023
FMS.NB Final Cash Dividend of gross USD 0.604856 paid on Jun 01, 2023 going ex on May 17, 2023
May 18, 2023
Jun 01, 2023
May 17, 2023
Apr 28, 2022
FMS.NB Final Cash Dividend of gross USD 0.708547 paid on May 27, 2022 going ex on May 13, 2022
May 16, 2022
May 27, 2022
May 13, 2022
May 16, 2021
FMS.NB Final Cash Dividend of gross USD 0.819276 paid on Jun 07, 2021 going ex on May 24, 2021
May 25, 2021
Jun 07, 2021
May 24, 2021
Aug 12, 2020
FMS.NB Final Cash Dividend of gross USD 0.71688 paid on Sep 11, 2020 going ex on Aug 28, 2020
Aug 31, 2020
Sep 11, 2020
Aug 28, 2020
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
常见问题
Fresenius Medical Care AG的前五大股东是谁？
Fresenius Medical Care AG 的前五大股东如下：
Pzena Investment Management, LLC持有股份：14.82M，占总股份比例：2.56%。
Wellington Management Company, LLP持有股份：8.20M，占总股份比例：1.42%。
Fiduciary Management, Inc.持有股份：5.46M，占总股份比例：0.94%。
Dodge & Cox持有股份：3.83M，占总股份比例：0.66%。
Todd Asset Management LLC持有股份：1.30M，占总股份比例：0.22%。
Pzena Investment Management, LLC持有股份：14.82M，占总股份比例：2.56%。
Wellington Management Company, LLP持有股份：8.20M，占总股份比例：1.42%。
Fiduciary Management, Inc.持有股份：5.46M，占总股份比例：0.94%。
Dodge & Cox持有股份：3.83M，占总股份比例：0.66%。
Todd Asset Management LLC持有股份：1.30M，占总股份比例：0.22%。
Fresenius Medical Care AG的前三大股东类型是什么？
Fresenius Medical Care AG 的前三大股东类型分别是：
Pzena Investment Management, LLC
Wellington Management Company, LLP
Fiduciary Management, Inc.
Pzena Investment Management, LLC
Wellington Management Company, LLP
Fiduciary Management, Inc.
有多少机构持有Fresenius Medical Care AG(FMS)的股份？
截至2025Q4，共有346家机构持有Fresenius Medical Care AG的股份，合计持有的股份价值约为46.58M，占公司总股份的8.04%。与2025Q3相比，机构持股有所增加，增幅为-0.08%。
哪个业务部门对Fresenius Medical Care AG的收入贡献最大？
在FY2024，--业务部门对Fresenius Medical Care AG的收入贡献最大，创收--，占总收入的--%。
